Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.57% | -80.86% | -277.05% | -270.01% | 3,260.38% |
| Total Depreciation and Amortization | -1.43% | -2.92% | 0.80% | -3.21% | 8.80% |
| Total Amortization of Deferred Charges | 138.26% | 134.64% | 88.11% | 80.63% | -38.81% |
| Total Other Non-Cash Items | 109.45% | 109.31% | 694.64% | 670.99% | -585.07% |
| Change in Net Operating Assets | -- | -- | -1,269.94% | -1,223.39% | -- |
| Cash from Operations | 1,118.77% | 1,103.36% | -65.72% | -67.08% | -111.28% |
| Capital Expenditure | -- | -- | -38.71% | -33.20% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 42,572.92% | 40,943.22% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -195.20% | -193.76% | 156.74% | 154.49% | -22.74% |
| Cash from Investing | -128.77% | -128.33% | 39.55% | 41.95% | 155.66% |
| Total Debt Issued | 60.65% | 60.65% | 62.36% | 62.36% | 12.73% |
| Total Debt Repaid | -21.37% | -21.37% | 19.61% | 19.61% | -28.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -719.36% | -719.36% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -5.44% | -1.24% | -- |
| Other Financing Activities | 1,746.89% | 1,746.89% | -2.47% | -2.47% | 16.70% |
| Cash from Financing | 157.24% | 156.38% | 12.23% | 15.72% | -55.60% |
| Foreign Exchange rate Adjustments | -80.82% | -81.14% | -86.42% | -86.96% | 57.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.26% | -9.65% | -108.07% | -99.79% | -16.63% |